Key Insights

Highlights

Success Rate

79% trial completion

Published Results

45 trials with published results (19%)

Research Maturity

106 completed trials (44% of total)

Clinical Risk Assessment

Based on trial outcomes

High Risk

Score: 59/100

Termination Rate

12.0%

29 terminated out of 242 trials

Success Rate

78.5%

-8.1% vs benchmark

Late-Stage Pipeline

7%

17 trials in Phase 3/4

Results Transparency

42%

45 of 106 completed with results

Key Signals

45 with results79% success29 terminated

Data Visualizations

Phase Distribution

202Total
Not Applicable (66)
Early P 1 (3)
P 1 (66)
P 2 (50)
P 3 (13)
P 4 (4)

Trial Status

Completed106
Recruiting49
Terminated29
Active Not Recruiting26
Unknown13
Not Yet Recruiting9

Trial Success Rate

78.5%

Benchmark: 86.6%

Based on 106 completed trials

Clinical Trials (242)

Showing 20 of 20 trials
NCT01329809Phase 2TerminatedPrimary

Neoadjuvant Recombinant Vaccinia Virus for Metastatic Colorectal Cancer With Liver Resection

NCT02465060Phase 2Active Not Recruiting

Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)

NCT07285044Phase 2Recruiting

The Cancer Connected Access and Remote Expertise Beyond Walls Program to Provide In-Home Cancer Treatment and Improve Treatment Satisfaction in Cancer Patients Living in the Florida Panhandle and Surrounding Areas

NCT05877599Phase 1Recruiting

A Study of NT-175 in Adult Participants With Advanced Malignancies That Are Positive for HLA-A*02:01 and the TP53 R175H Mutation

NCT06218914Phase 1Recruiting

Phase 1 Study to Investigate TCRTs KRAS Mutation in Unresectable, Advanced, and/or Metastatic Solid Tumors

NCT06882746Phase 1TerminatedPrimary

A Study to Test Different Doses of BI 765049 in People With Advanced Cancer of the Colon, Rectum, Stomach, or Pancreas

NCT05786924Phase 1Recruiting

Phase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies

NCT03804255Withdrawn

Assessment of Current Biomarker Testing Practices for Common Solid Cancers in Precision Oncology in the Community Setting

NCT03151564Not ApplicableActive Not Recruiting

Lesion Detection Assessment in the Liver: Standard vs Low Radiation Dose Using Varied Post-Processing Techniques

NCT06557733Phase 2RecruitingPrimary

An Investigational Drug (TPST-1495) in Patients With Familial Adenomatous Polyposis

NCT02134925Phase 2Active Not Recruiting

Vaccine Therapy in Treating Patients With Newly Diagnosed Advanced Colon Polyps

NCT05630794Phase 1Recruiting

Testing for Safety and Colorectal Cancer Preventive Effects of ONC201

NCT04905082Not ApplicableActive Not Recruiting

HOPE-Genomics Intervention for the Improvement of Cancer Patient Knowledge of Genomics

NCT07035691RecruitingPrimary

New bioMarkers tO straTIfy cOlorectal caNcer Referrals

NCT05930496Not ApplicableTerminated

Evaluating the Effects of an Exercise Intervention on the Gut Microbiota in Stage II-III Colorectal Cancer Survivors

NCT06568016Not ApplicableRecruitingPrimary

A Clinic-wide Intervention (Primary Care-GI Connect) for Improving Rates of Colonoscopy After Abnormal Fecal Immunochemical Test Result in Patients at Federally Qualified Health Centers

NCT06995898Not ApplicableRecruiting

The Vanguard Study: Testing a New Way to Screen for Cancer

NCT07782164RecruitingPrimary

Irreversible Electroporation (IRE) for Treating Recurrent Pelvic Tumors (PELFIRE Study)

NCT07790718Not ApplicableRecruiting

Testing the Effects of Exercise on Colorectal Cancer Development After Treatment With Pelvic Radiation Therapy for Prostate Cancer

NCT03366155Phase 2Completed

Hepatic Artery Infusion Pump Chemotherapy With Floxuridine and Dexamethasone in Combination With Systemic Chemotherapy for Patients With Colorectal Cancer Metastatic to the Liver

Scroll to load more

Research Network

Activity Timeline